Emil Lou, assistant professor of medicine, Division of Hematology, Oncology, and Transplantation, was appointed medical director of the Masonic Cancer Center Clinical Trials Office.
Richard Pazdur, FDA’s top oncologist who last week received a battlefield promotion to the role of director of the FDA Center for Drug Evaluation and Research, is described as a stabilizing figure respected by major patient groups, oncology professional societies, and the industry.
